Flagship explainer

How TriSalus Life Sciences, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$45.2M · 100%Cost of revenue$7M · 15%Gross profit$38.2M · 85%Operating income−$26.9M · −60%Income before tax−$39.2M · −87%Income tax$7000 · 0%Net income−$39.2M · −87%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$45.2M100%
Cost of revenue$7M15%
$38.2M85%
−$26.9M−60%
Income before tax−$39.2M−87%
Income tax$70000%
−$39.2M−87%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full TriSalus Life Sciences, Inc. analysis at Buy Like Buffett